Kallmann's syndrome
Kallmann's syndrome is a genetic disorder characterized by hypogonadotropic hypogonadism (a condition causing low levels of sex hormones) and anosmia (the inability to smell). It is named after the German-American physician Franz Josef Kallmann, who first described the condition in 1944.
Etiology[edit | edit source]
Kallmann's syndrome is caused by a disruption in the development of the hypothalamus, a region of the brain that controls the release of hormones from the pituitary gland. This disruption results in a deficiency of gonadotropin-releasing hormone (GnRH), which is essential for sexual development and reproduction.
Symptoms[edit | edit source]
The primary symptoms of Kallmann's syndrome are delayed or absent puberty and a reduced or absent sense of smell. Other symptoms can include cryptorchidism (undescended testicles) in males, amenorrhea (absence of menstrual periods) in females, and infertility in both sexes.
Diagnosis[edit | edit source]
Diagnosis of Kallmann's syndrome is typically based on the presence of the characteristic symptoms, particularly delayed puberty and anosmia. Additional tests may include a blood test to measure hormone levels, MRI to examine the brain and olfactory system, and genetic testing to identify any mutations associated with the condition.
Treatment[edit | edit source]
Treatment for Kallmann's syndrome primarily involves hormone replacement therapy to induce puberty and maintain normal hormone levels. In some cases, fertility treatments may be used to help individuals with the condition conceive children.
Prognosis[edit | edit source]
With appropriate treatment, individuals with Kallmann's syndrome can lead normal lives. However, they may require lifelong hormone replacement therapy and may have difficulties with fertility.
See also[edit | edit source]
NIH genetic and rare disease info[edit source]
Kallmann's syndrome is a rare disease.
| Kallmann's syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
